tiprankstipranks
Advertisement
Advertisement

HK:2552 Stock Latest News

Hua Medicine Doubles Diabetes Drug Revenue and Secures Hong Kong Approval for Dorzagliatin
Company AnnouncementsHua Medicine Doubles Diabetes Drug Revenue and Secures Hong Kong Approval for Dorzagliatin
19d ago
Hua Medicine Reshuffles Company Secretary and Authorised Representative Roles
PremiumCompany Announcements
Hua Medicine Reshuffles Company Secretary and Authorised Representative Roles
19d ago
Hua Medicine Relocates Hong Kong Principal Place of Business
PremiumCompany Announcements
Hua Medicine Relocates Hong Kong Principal Place of Business
22d ago
Hua Medicine Sets March 26 Board Meeting to Approve 2025 Results
PremiumCompany Announcements
Hua Medicine Sets March 26 Board Meeting to Approve 2025 Results
29d ago
Hua Medicine Wins Hong Kong Approval for Pioneering Diabetes Drug Dorzagliatin
PremiumCompany Announcements
Hua Medicine Wins Hong Kong Approval for Pioneering Diabetes Drug Dorzagliatin
1M ago
Hua Medicine Advances Diabetes Treatment with New Phase Ib Trial
PremiumCompany AnnouncementsHua Medicine Advances Diabetes Treatment with New Phase Ib Trial
4M ago
Hua Medicine Grants Share Options to Drive Growth and Commitment
Premium
Company Announcements
Hua Medicine Grants Share Options to Drive Growth and Commitment
4M ago
Hua Medicine Announces Changes to Remuneration Committee
Premium
Company Announcements
Hua Medicine Announces Changes to Remuneration Committee
5M ago
Hua Medicine Updates Board of Directors and Committee Roles
PremiumCompany Announcements
Hua Medicine Updates Board of Directors and Committee Roles
5M ago
Hua Medicine Reports Strong Growth in 2025
PremiumCompany Announcements
Hua Medicine Reports Strong Growth in 2025
8M ago
Hua Medicine Reports Strong Growth and Strategic Advancements in 2025 Interim Results
PremiumCompany Announcements
Hua Medicine Reports Strong Growth and Strategic Advancements in 2025 Interim Results
8M ago
Hua Medicine Schedules Board Meeting to Review Interim Results
PremiumCompany Announcements
Hua Medicine Schedules Board Meeting to Review Interim Results
8M ago
Hua Medicine Reports Significant Profit Turnaround in H1 2025
PremiumCompany AnnouncementsHua Medicine Reports Significant Profit Turnaround in H1 2025
9M ago
Hua Medicine Secures Shareholder Approval for Key Resolutions at AGM
Premium
Company Announcements
Hua Medicine Secures Shareholder Approval for Key Resolutions at AGM
10M ago
Hua Medicine Announces Board Restructuring to Enhance Governance
Premium
Company Announcements
Hua Medicine Announces Board Restructuring to Enhance Governance
10M ago
Hua Medicine Announces Resignation of Non-Executive Director
PremiumCompany Announcements
Hua Medicine Announces Resignation of Non-Executive Director
10M ago
Hua Medicine Announces Key Resolutions for Upcoming AGM
PremiumCompany Announcements
Hua Medicine Announces Key Resolutions for Upcoming AGM
12M ago
Hua Medicine Grants 9.7 Million Share Options to Key Personnel
PremiumCompany Announcements
Hua Medicine Grants 9.7 Million Share Options to Key Personnel
1y ago
Hua Medicine Reports Strong Revenue Growth in 2024
PremiumCompany Announcements
Hua Medicine Reports Strong Revenue Growth in 2024
1y ago
Hua Medicine Reports Strong 2024 Sales and Strategic Expansion Plans
PremiumCompany AnnouncementsHua Medicine Reports Strong 2024 Sales and Strategic Expansion Plans
1y ago
Hua Medicine Schedules Board Meeting for Financial Results and Dividend Consideration
Premium
Company Announcements
Hua Medicine Schedules Board Meeting for Financial Results and Dividend Consideration
1y ago
Hua Medicine to Lead HuaTangNing Sales in China
Premium
Company Announcements
Hua Medicine to Lead HuaTangNing Sales in China
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >